Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S18 pseudogene 8, abbreviated as RPS18P8, represents a processed pseudogene related to the ribosomal protein S18 gene family. Pseudogenes are genomic elements that arise from gene duplication or retrotransposition events but generally lack the ability to encode a functional protein, often due to mutations that disrupt normal gene expression or translation. There is no evidence that RPS18P8 produces a functional molecule or plays a direct role in human biology or disease. Like other ribosomal protein pseudogenes, RPS18P8 is not considered a therapeutic target, does not interact with pharmaceuticals, and is not used as a biomarker in clinical practice[5][7]. Available gene and protein databases do not list biological functions, disease involvement, or molecular interactions for this entity, further supporting its classification as a non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S18 pseudogene 8 (RPS18P8).